The Use of Unfractionated Heparin and Low Molecular Weight Heparins in Pregnancy

Ginsberg, 1989, Heparin therapy during pregnancy: risks to the fetus and the mother, Arch Intern Med, 149, 2233, 10.1001/archinte.1989.00390100059015

Ginsberg, 1989, Risks to the fetus of anticoagulant therapy during pregnancy, Thromb Haemost, 61, 197, 10.1055/s-0038-1646558

Basu, 1972, A prospective study of the value of monitoring heparin treatment with the activated partial thromboplastin time, N Engl J Med, 279, 324, 10.1056/NEJM197208172870703

Chiu, 1977, Relationship between the anticoagulant and antithrombotic effects of heparin in experimental venous thrombosis, Blood, 49, 171, 10.1182/blood.V49.2.171.171

Hirsh, 1991, Drug Therapy, NEJM, 234, 1565

Hirsh, 1992, Low molecular weight heparin, Blood, 79, 1, 10.1182/blood.V79.1.1.1

Bates, 2004, Use of antithrombotic agents during pregnancy: the seventh ACCP conference on antithrombotic and thrombolytic therapy, Chest, 126, 627S, 10.1378/chest.126.3_suppl.627S

Bergqvist, 1985, Recurrent thromboemboism in pregnancy and puerperium, Am J Obstet Gynecol, 28, 107

Ginsberg, 1992, Venous thrombosis during pregnancy; leg and trimester of presentation, Thromb Haemost, 67, 519, 10.1055/s-0038-1648485

Rutherford, 1991, Thromboembolic disease associated with pregnancy: an 11 year review (abstract), Am J Obstet Gynecol, 164, 286, 10.1016/0002-9378(91)90879-V

Bergqvist, 1983, Deep vein thrombosis during pregnancy: a prospective study, Acta Obstet Gynecol Scand, 62, 443, 10.3109/00016348309154217

Buller, 2004, Antithrombotic therapy for venous thromboembolic disease: the seventh ACCP Conference on Antithrombotic and thrombolytic therapy, Chest, 126, 401S, 10.1378/chest.126.3_suppl.401S

Weiner, 1985, Diagnosis and management of thromboembolic disease in pregnancy, Clin Obste Gynecol, 28, 107, 10.1097/00003081-198528010-00012

Barbour, 1995, Heparin levels to guide thromboembolism thromboprophylaxis during pregnancy, Am J Obstet Gynecol, 173, 1869, 10.1016/0002-9378(95)90443-3

Dahlman, 1993, Osteoporotic fractures and the recurrence of thromboembolism in pregnancy and puerperium in 184 women undergoing thromboprophylaxis with heparin, Am J Obste Gynecol, 168, 1265, 10.1016/0002-9378(93)90378-V

Dahlman, 1989, Thrombosis prophylaxis in pregnancy with use of subcutaneous heparin adjusted by monitoring heparin concentration in plasma, Am J Obstet Gynecol, 161, 402, 10.1016/0002-9378(89)90535-8

Brancazio, 1995, Pharmacokinetics and pharmacodynamics of subcutaneous heparin during the early third trimester of pregnancy, Am J Obstet Gynecol, 173, 1240, 10.1016/0002-9378(95)91362-9

Losito, 1985, Molecular weight of heparin versus biological activity, Semin Thromb Hemostasis, 11, 29, 10.1055/s-2007-1004355

Fareed, 1996, Are the available low molecular weight heparin preparations the same?, Semin Thromb Hemostasis, 22, 77

Laurent, 2002, Low molecular weight heparins: a guide to their optimum use in pregnancy, Drugs, 62, 463, 10.2165/00003495-200262030-00004

Omri, 1989, Low molecular weight heparin novo (LHN-1) does not cross the placenta during the second trimester of pregnancy, Thromb Haemost, 1, 55

Dimitrakakis, 2000, Absence of transplacental passage of low molecular weight heparin enoxaparin, Haemostasis, 30, 243

Harenberg, 1993, Lack of anti-factor Xa activity in umbilical cord vein samples after subcuataneous administration of heparin or low molecular weight heparin in pregnant women, Thromb Haemost, 23, 314

Weitz, 1997, Low molecular weight heparins, NEJM, 337, 688, 10.1056/NEJM199709043371007

Harenberg, 1986, Bioavailability and antagonization of the low molecular weight heparin CY216 in man, Thromb Res, 44, 549, 10.1016/0049-3848(86)90333-6

Casele, 1999, Venkataramanan Changes in the pharmokinetics of the low molecular weight heparin enoxaparin sodium during pregnancy, Am J Obstet Gynecol, 181, 1113, 10.1016/S0002-9378(99)70091-8

Gould, 1999, Low molecular weight heparins compared with unfractionated heparin for treatment of acute venous thrombosis: a meta-analysis of randomized, controlled trials, Ann Intern Med, 130, 800, 10.7326/0003-4819-130-10-199905180-00003

Nurmohamed, 1992, Low molecular weight heparin versus standard heparin in general and orthopedic surgery: a meta-analysis, Lancet, 340, 152, 10.1016/0140-6736(92)93223-A

Dolovich, 2000, A meta-analysis comparing low molecular weight heparins to unfractionated heparin in the treatment of venous thromboembolism examining some unanswered questions regarding location of treatment, product type and dosing frequency, Arch Intern Med, 160, 181, 10.1001/archinte.160.2.181

Pettila, 1999, Thromboprophylaxis with low molecular weight heparin (dalteparin) in pregnancy, Thromb Res, 96, 275, 10.1016/S0049-3848(99)00110-3

Holm, 1986, Subcutaneous heparin treatment and deep vein thrombosis: a comparison of unfractionated and low molecular weight heparin, Haemostasis, 16, 30

Faivre, 1987, Subcutaneous administration of low molecular weight heparin CY 222 compared with subcutaneous administration of standard heparin in patients with acute deep vein thrombosis, (Abstr) Thromb Haemost, 58, 430

Bratt, 1985, A comparison between low molecular weight heparin (Kabi 2165) and standard heparin in the intravenous treatment of deep vein thrombosis (DVT), Thromb Haemost, 54, 813, 10.1055/s-0038-1660139

Bratt, 1990, Two daily subcutaneous injection of Fragmin as compared with intravenous standard heparin in the treatment of deep venous thrombosis (DVT), Thromb Haemost, 64, 506, 10.1055/s-0038-1647348

Hull, 1992, Subcutaneous low molecular weight heparin compared with continuous intravenous heparin in the treatment of proximal vein thrombosis, N Engl J Med, 326, 975, 10.1056/NEJM199204093261502

Duroux, 1991, A randomized trial of subcutaneous low molecular weight heparin (CY216) compared with intravenous unfractionated heparin in the treatment of deep vein thrombosis, Thromb Haemost, 65, 251, 10.1055/s-0038-1647660

Simmoneau, 1991, Subcutaneous fixed dose of enoxaparin versus intravenous adjusted dose of unfractionated heparin in the treatment of deep venous thrombosis, Thromb Haemost (Abstr), 65, 754

Prandoni, 1992, Comparison of subcutaneous low molecular weight heparin with intravenous standard heparin in proximal deep-vein thrombosis, Lancet, 339, 441, 10.1016/0140-6736(92)91054-C

Lopaciuk, 1992, Subcutaneous low molecular weight heparin versus subcutaneous unfractionated heparin in the treatment of deep vein thrombosis. A Polish ulitcenter Trial, Thromb Haemost, 68, 14, 10.1055/s-0038-1656309

Lensing, 1995, Treatment of deep venous thrombosis with low molecular weight heparins: a meta-analysis, Arch Intern Med, 155, 601, 10.1001/archinte.1995.00430060059007

Hirsh, 1996, Comparison of the relative efficacy and safety of low molecular weight heparin and unfractionated heparin for the treatment of venous thrombosis, Semin Thromb Hemost, 22, 7

Hague, 2001, Anticoagulation in pregnancy and puerperium, Med J Aust, 175, 258, 10.5694/j.1326-5377.2001.tb143561.x

Kearon, 1997, Management of anticoagulation before and after elective surgery, N Engl J Med, 336, 1506, 10.1056/NEJM199705223362107

2002, Anticoagulation and enoxaparin use in patients with prosthetic heart valves and/or pregnancy, Clin Cardiol Consensus Rep, 3, 1

Griffith, 1965, Heparin osteoporosis, JAMA, 193, 915, 10.1001/jama.1965.03090020005001

Dahlman, 1993, Osteoporotic fractures and the recurrence of thromboembolism during pregnancy and puerperium in 184 women undergoing thromboprophylaxis with heparin, Am J Obstet Gynecol, 168, 1265, 10.1016/0002-9378(93)90378-V

Dahlman, 1994, Bone mineral density during long-term prophylaxis with heparin in pregnancy, Am J Obstet Gynecol, 170, 1315, 10.1016/S0002-9378(13)90457-9

Barbour, 1994, A prospective study of heparin-induced osteoporosis in pregnancy using bone densitometry, Am J Obste Gynecol, 170, 862, 10.1016/S0002-9378(94)70299-3

Matzsch, 1990, Effects of low molecular weight heparin and unfractionated heparin on induction of osteoporosis in rats, Thromb Haemost, 63, 505, 10.1055/s-0038-1645074

Monreal, 1990, Heparin-related osteoporosis in rats. A comparative study between unfractionated heparin and low molecular weight heparin, Haemost, 20, 204

Ginsberg, 1990, Heparin effect on bone density, Thromb Haemost, 64, 286, 10.1055/s-0038-1647302

Casele, 2000, Prospective evaluation of bone density in pregnant women receiving the low molecular weight heparin enoxaparin sodium, J Maternal Fetal Medicine, 9, 122

Casele, 2005, Bone Density Changes in Women Receiving Thromboprophyalxis in Pregnancy, Am J Obstet Gynecol, 193, S14, 10.1016/j.ajog.2005.10.036

Casele, 2005, Bruising in women undergoing thromboprophylaxis in pregnancy, Am J Obstet Gynecol, 193, S81, 10.1016/j.ajog.2005.10.552